Your browser is no longer supported. Please, upgrade your browser.
Surmodics, Inc.
Index- P/E595.58 EPS (ttm)0.08 Insider Own2.90% Shs Outstand13.48M Perf Week0.95%
Market Cap648.00M Forward P/E179.84 EPS next Y0.26 Insider Trans-3.07% Shs Float13.19M Perf Month15.72%
Income1.10M PEG59.56 EPS next Q-0.07 Inst Own90.40% Short Float3.03% Perf Quarter12.43%
Sales94.90M P/S6.83 EPS this Y-85.20% Inst Trans0.34% Short Ratio8.81 Perf Half Y-4.68%
Book/sh9.72 P/B4.72 EPS next Y100.79% ROA0.70% Target Price64.25 Perf Year10.91%
Cash/sh4.32 P/C10.61 EPS next 5Y10.00% ROE0.90% 52W Range22.06 - 49.00 Perf YTD5.38%
Dividend- P/FCF62.91 EPS past 5Y-38.20% ROI1.00% 52W High-6.41% Beta1.02
Dividend %- Quick Ratio4.30 Sales past 5Y8.90% Gross Margin83.90% 52W Low107.89% ATR2.00
Employees370 Current Ratio4.60 Sales Q/Q-26.90% Oper. Margin-1.40% RSI (14)62.96 Volatility5.27% 4.71%
OptionableYes Debt/Eq0.00 EPS Q/Q-184.80% Profit Margin1.20% Rel Volume0.82 Prev Close44.75
ShortableYes LT Debt/Eq0.00 EarningsNov 04 AMC Payout0.00% Avg Volume45.37K Price45.86
Recom1.50 SMA206.01% SMA5013.15% SMA20012.35% Volume37,317 Change2.48%
Jul-23-20Upgrade Needham Hold → Buy
Dec-11-19Downgrade Needham Buy → Hold
Nov-01-19Downgrade Lake Street Buy → Hold $75 → $50
Aug-01-19Reiterated Needham Buy $65 → $68
May-02-19Reiterated Needham Buy $74 → $65
May-02-19Reiterated Lake Street Buy $90 → $75
Feb-21-19Reiterated Needham Buy $69 → $74
May-16-18Reiterated Needham Buy $46 → $55
Mar-01-18Upgrade Sidoti Neutral → Buy
Feb-28-18Reiterated Lake Street Buy $35 → $38
Feb-28-18Initiated Needham Buy $42
Jul-14-17Initiated Lake Street Buy $40
Nov-21-16Downgrade Barrington Research Outperform → Mkt Perform
Oct-06-16Downgrade Sidoti Buy → Neutral
May-03-16Reiterated Barrington Research Outperform $27 → $30
Aug-06-15Reiterated Barrington Research Outperform $28 → $29
Mar-27-15Initiated Dougherty & Company Buy $33
Feb-25-14Initiated Laidlaw Buy $30
Aug-01-13Upgrade Feltl & Co. Buy → Strong Buy $31.25
Nov-12-12Reiterated Barrington Research Outperform $20 → $22
Jan-20-21 11:40AM  
Jan-12-21 08:05AM  
Dec-16-20 10:28AM  
Dec-04-20 11:31AM  
Nov-09-20 08:05AM  
Nov-05-20 09:13AM  
Nov-04-20 06:05PM  
Oct-28-20 12:32PM  
Oct-27-20 08:30AM  
Oct-22-20 12:33PM  
Oct-12-20 11:40AM  
Sep-29-20 09:06AM  
Sep-23-20 08:30AM  
Sep-15-20 08:20AM  
Sep-04-20 11:31AM  
Aug-10-20 08:17AM  
Aug-07-20 11:39AM  
Aug-05-20 06:15PM  
Jul-29-20 12:33PM  
Jul-28-20 08:30AM  
Jul-22-20 12:32PM  
Jul-14-20 11:40AM  
Jul-08-20 08:39AM  
Jul-05-20 05:45PM  
Jul-01-20 08:49AM  
Jun-30-20 06:57AM  
Jun-29-20 10:12AM  
Jun-26-20 09:09AM  
Jun-25-20 07:53AM  
Jun-23-20 09:24AM  
Jun-17-20 06:28AM  
Jun-16-20 08:45AM  
Jun-12-20 12:20PM  
Jun-10-20 09:50AM  
Jun-09-20 08:02AM  
Jun-08-20 08:30AM  
Jun-03-20 10:07AM  
Jun-02-20 11:11AM  
Jun-01-20 09:59AM  
May-29-20 11:31AM  
May-28-20 09:43AM  
May-27-20 10:03AM  
May-26-20 10:02AM  
May-20-20 07:43AM  
May-19-20 10:47AM  
May-18-20 11:55AM  
May-14-20 08:30AM  
May-01-20 10:31AM  
Apr-30-20 09:24PM  
Apr-29-20 07:05PM  
Apr-27-20 08:28AM  
Apr-22-20 12:31PM  
Apr-21-20 02:10PM  
Apr-20-20 08:27AM  
Apr-15-20 08:26AM  
Apr-09-20 09:35AM  
Apr-02-20 07:11AM  
Mar-21-20 10:54AM  
Mar-06-20 11:30AM  
Feb-20-20 09:54AM  
Feb-10-20 06:29PM  
Feb-06-20 10:03AM  
Feb-05-20 06:25PM  
Feb-03-20 08:30AM  
Jan-29-20 12:31PM  
Jan-28-20 08:30AM  
Jan-22-20 12:31PM  
Jan-15-20 02:13PM  
Jan-07-20 07:46AM  
Dec-24-19 11:03AM  
Dec-16-19 11:53AM  
Dec-13-19 03:28PM  
Nov-25-19 08:00AM  
Nov-14-19 10:38AM  
Nov-05-19 07:50AM  
Nov-04-19 07:35AM  
Oct-31-19 05:45PM  
Oct-30-19 08:33PM  
Oct-29-19 08:30AM  
Oct-25-19 08:30AM  
Oct-24-19 10:26AM  
Oct-23-19 07:40AM  
Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. The company operates through two segments, Medical Device and In Vitro Diagnostics. The Medical Device segment engages in the provision of surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices; and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device for coronary, peripheral, neuro-vascular and structural heart, and other markets, as well as design, development, and manufacturing of interventional medical devices, primarily balloons and catheters, including drug-coated balloons for peripheral arterial disease treatment and other applications. The Vitro Diagnostics segment designs, develops, and manufactures component products and technologies for diagnostic immunoassay, as well as molecular test and biomedical research applications. This segment offers protein stabilization reagents, substrates, surface coatings, and antigens. Surmodics, Inc. was founded in 1979 and is headquartered in Eden Prairie, Minnesota.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Stich Joseph J.SVP, HR and GM, IVDJan 05Sale45.002,500112,50050,562Jan 07 04:37 PM
Maharaj Gary RPresident & CEOJan 04Sale43.962,00087,926145,142Jan 06 04:25 PM
BEDOYA JOSE HDirectorNov 17Option Exercise22.583,57580,72425,325Nov 19 05:06 PM
DANTZKER DAVIDDirectorNov 10Option Exercise22.583,57580,72430,471Nov 13 04:20 PM
Maharaj Gary RPresident & CEOSep 01Sale45.073,000135,206135,399Sep 03 05:06 PM
Stich Joseph J.SVP, HR and GM, IVDAug 19Sale46.712,500116,78151,570Aug 21 03:20 PM
Maharaj Gary RPresident & CEOAug 03Sale47.443,000142,334138,142Aug 05 04:28 PM
Stich Joseph J.SVP, HR and GM, IVDJul 22Option Exercise22.5812,612284,77963,488Jul 24 05:24 PM
Maharaj Gary RPresident & CEOJul 01Sale43.022,00086,037141,142Jul 06 06:10 PM
Stich Joseph J.SVP, HR and GM, IVDJun 09Sale45.002,500112,50051,499Jun 11 05:47 PM
BEDOYA JOSE HDirectorFeb 20Sale37.511,82168,31421,750Feb 24 04:25 PM